Egyptian Journal of Surgery [The]. 1999; 18 (3): 246-250
en Inglés
| IMEMR
| ID: emr-118382
ABSTRACT
Studies of intraoperative angiography have shown residual distal thrombi in 30% of patients undergoing emboloectomy. Both streptokinase and urokinase have been used intraoperatively to Iyse such thrombi. Side effects inclinde anaphylaxis, wound hoematoma, and systemic hypofibrinogenaemia. In this study recombinant tissue plasminogcn activator [rtPA] was used to lyse residual thrombi in 18 patients after transfemoral embolectomy. Complete lysis was achieved in 10 patients [55.5%], partial lysis in 5 patients [27.8%] and only 3 patients [16.7%] had no response. Limb salvage rate was 72.2%. There were no reported cases of allergic reactions, wound haematomas, or coagulation problems. The study shows that intraoperative tissue plasmoinogen activator [rtPA] is safe and effective in losing residual postembolectomy thrombi. Its use may avoid the need for more distal exploration
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Fibrinógeno
/
Activador de Tejido Plasminógeno
/
Embolectomía
/
Recuperación del Miembro
/
Extremidad Inferior
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Egypt. J. Surg.
Año:
1999
Similares
MEDLINE
...
LILACS
LIS